10.03.2020
NEXUS AG: Successful Annual Result in 2019 with Substantial Sales and Revenue GrowthIn 2019, sales improved from KEUR 136,469 to KEUR 147,648 (+8.2 %). The “Healthcare Software” division increased its sales from KEUR 125,904 to KEUR 139,597 (+10.9 %), and the “Healthcare Service” division had a decrease from KEUR 10,565 in 2018 to KEUR 8,051 as part of realignment. The international share of total business volume was 46.7 % (previous year: 46.0 %) and amounted to KEUR 68,901 compared to KEUR 62,769 in the previous year. The Group result before interest and taxes (EBT) increased considerably by 14.9 % to KEUR 17,444 (previous year: KEUR 15,181). The result before taxes (EBT) reached KEUR 16,862 following KEUR 14,929 in the previous year’s period (+12.9 %). EBITA increased by 18.2 % from KEUR 18,335 (2018) to KEUR 21,676. EBITDA increased by 27.1 % to KEUR 33,947 (previous year: KEUR 26,708) during the reporting period. Adjusted for the IFRS 16 effect, EBITDA increased by 10.7 %.
At the annual general meeting on 30 April 2020, the Supervisory Board and the Executive Board will propose to pay a dividend of EUR 0.18 per share. |